If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost down from around $500 a month to $31.60.
Articles on Novo Nordisk
Displaying all articles
Anti-obesity medications are becoming the go-to treatment for weight loss. But drugs alone may not provide the same benefits as lifestyle choices like exercise and a healthy diet.
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
Top contributors
-
Professor of Exercise Science and Interim Dean of the School of Health Sciences, College of Charleston
-
Executive Director of the Value of Life Sciences Innovation program; Fellow at the USC Schaeffer Center, University of Southern California
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Professor of Health Economics, Flinders University